XLO Xilio Therapeutics Inc Company Short-Term Debt

Xilio Therapeutics (XLO) - corporate logo

Xilio Therapeutics, Inc. (XLO) dynamics are driven by a dependence on Gilead payments and R&D expenditures. The history of short-term liabilities demonstrates the current state of debt, where 0.00 shows the current volume of this metric. The business model relies on third-party antibody synthesis contractors. Meanwhile, high competition in tumor therapy and potential drug side effects during trials create significant challenges.

Xilio (XLO) - Company Short-Term Loans and Borrowings from 07/04/2022 to 11/01/2026

Summary analytical data breakdowns for Xilio Therapeutics Inc (XLO)

- stock price and consensus target price:
Stock Price Xilio|XLO - Average Forecast Price
- market capitalization data:
Market Value Xilio Therapeutics, Inc.|XLO - Value Adjusted for Debt and Cash
- shareholders' equity book value data:
Accounting Value per Share Xilio Therapeutics|XLO - Accounting Value of Company|Market Capitalization to Book Value Ratio xiliotx.com|XLO - Cumulative Company Assets
- debt obligations and liquidity statistics:
Total Debt to Equity Ratio Xilio Therapeutics, Inc.|XLO - Long-Term Debt to Capital|Short-Term Debt to Equity Xilio|XLO - Aggregate Debt Obligations|Debts to Book Capitalization Xilio Therapeutics, Inc.|XLO - Long-Term Debt|Company Current Liabilities Xilio Therapeutics|Quick Ratio xiliotx.com
- earnings and valuation multiples indicators:
XLO - Net Financial Result
General company analysis:xiliotx.com (XLO)
Flagship merchandise of Xilio

This metric aggregates all of the issuer's financial obligations with a maturity of less than twelve months, measuring the current liquidity burden. Given the loss-making R&D and the dependence of Xilio Therapeutics, Inc. (XLO) on payments from Gilead, an increase in total short-term liabilities signals a critical risk of a cash crunch in the event of delayed partner payments or negative clinical trial results.

Main competitors

BeiGene - Company Short-Term Debts|Short-Term Debt Halozyme Therapeutics, Inc.|RevMed (RVMD) - Company Short-Term Debt|Ascentage Pharma Corp - Company Short-Term Loans and Borrowings|Company Current Liabilities CGON|URGN: Company Short-Term Loans and Borrowings|Company Short-Term Debts BCAX|Company Current Liabilities Personalis Inc PSNL|Erasca Corp - Company Current Liabilities|Company Short-Term Debts Delcath Corp DCTH|YMAB - Company Short-Term Debt|Company Short-Term Loans and Borrowings AURA (aurabiosciences.com)|CADL: Company Short-Term Debts|Short-Term Debt Accuray Inc (ARAY)|Company Current Liabilities SLS|Company Short-Term Indebtedness ACTU (Actuate Therapeutics Inc)|Company Short-Term Debts CTOR|Short-Term Debt Volume tuhurabio.com|Company Short-Term Debt Protara Therapeutics, Inc. TARA|Fate Therapeutics Inc - Company Short-Term Debt|Aadi Bio - Company Short-Term Debts|Short-Term Debt Volume TScan Therapeutics TCRX|championsoncology.com (CSBR) - Company Short-Term Debt|Short-Term Debt XBiotech (XBIT)|Company Current Liabilities CVM|OSTX: Company Short-Term Loans and Borrowings|Company Current Liabilities RADX (Radiopharm Theranostics)|Amount of Current Liabilities ARTV|Company Short-Term Debts ANL (Adlai Nortye)|Company Short-Term Loans and Borrowings VERU|Tempest Therapeutics, Inc. - Company Short-Term Debts|Short-Term Debt Renovaro Inc.|muraloncology.com (MURA) - Company Short-Term Debt|Kairos Pharma - Company Short-Term Loans and Borrowings|OKUR (OnKure Therapeutics, Inc.) - Company Short-Term Debts|Company Short-Term Debts CytoMed|Company Short-Term Debt Curis, Inc. (CRIS)|APLM: Current Liabilities|Company Short-Term Debts THAR (Tharimmune Corp)|Advanced Biomed Inc. (ADVB) - Short-Term Debt|GNPX: Company Current Liabilities|CLDI - Company Short-Term Debts|SBFM (Sunshine Biopharma) - Company Current Liabilities|XBIO: Amount of Current Liabilities|SLRX (Salarius) - Company Short-Term Debts|Kitov Pharma (PPBT) - Short-Term Debt Volume|Company Short-Term Debts AONC|Company Current Liabilities beigene.com BGNE|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|Short-Term Debt Volume Elevation Oncology Inc. (ELEV)|ICAD: Company Current Liabilities|Company Short-Term Loans and Borrowings IKNA (Ikena Oncology, Inc.)|NTBL: Company Short-Term Debts|VIRX - Short-Term Debt Volume|Company Short-Term Debt MorphoSys|Company Short-Term Indebtedness NAYA (NAYA Biosciences Inc)|Company Short-Term Debts AAPGV